Sitafloxacin
Jump to navigation
Jump to search
Template:Short description Template:Drugbox
Sitafloxacin (INN; also called DU-6859a) is a fluoroquinolone antibiotic[1] that shows promise in the treatment of Buruli ulcer. The molecule was identified by Daiichi Sankyo Co., which brought ofloxacin and levofloxacin to the market. Sitafloxacin is currently marketed in Japan by Daiichi Sankyo under the tradename Gracevit.Script error: No such module "Unsubst".
See also
References
Further reading
- Script error: No such module "Citation/CS1".
External links
- Template:In lang Gracevit グレースビット (PDF) Daiichi Sankyo Co. January 2008.
Script error: No such module "Navbox".
- ↑ Script error: No such module "Citation/CS1".